Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
Summary
Cosmos Health says its subsidiary Cana Laboratories has acquired an international patent application and is pursuing protection in multiple markets. The company plans to use the technology to expand nanotechnology-based product development across pharmaceuticals, nutraceuticals, OTC, and specialized healthcare products. It also wants to combine the IP with its GMP-certified manufacturing capabilities to strengthen vertical integration and commercialization. The move fits into a broader strategy of building a larger innovation portfolio and creating differentiated healthcare products.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected